




Endurant Health Fund LP - Pooled Investment Fund- Endurant Capital Management Lp  FormDs.com - SEC filings of fundraisings and investments in hedge funds, private equity firms, startups, and growing companies 











 FormDs.com 





 Newest
 Filter
 Local




 









Endurant Health Fund LP

      Industry: Pooled Investment Fund
      (See others in industry)

Address:



    1825 South Grant Street Suite 425 
    San Mateo, CA, 94402Phone: 650-539-5905 




Filings



Date
FilingType
Reported Sold
Incremental Cash 
Type
Exemptions
Link to Raw Filing




	2016-11-04


Amended


$27,420,911


$0


Other


06b 3C 3C.7


SEC link




	2015-11-04


Amended


$120,000,000


$0


Other


06b 3C 3C.7


SEC link




	2014-11-06


Amended


$100,000,000


$11,920,911


Other


06b 3C 3C.7


SEC link




	2013-10-08


New


$15,500,000


$15,500,000


Other


06b 3C 3C.7


SEC link






Directors and Executives (Current and Past)



Name
Role



 N/A Endurant Capital Management Lp 
 Promoter 


 Pham Quang 
 Executive 


 Vishal Saluja 
 Executive 





















 


 

Endurant Health Fund Lp raised $100,000,000 on November 6th, 2014































Want to see more?Want to find out who got funded, and who’s funding the next big thing? in real time? all across the world? tailored to your specific areas of focus?100+ deals per dayGet access to the most exhaustive worldwide funding watch on the web!Comprehensive funding informationKnow about who invested in a company, which sites covered the event, the funding history, etc.Exclusive insightsView original analytics such as most dynamic industries, most active investors, and more!Stay aware!Get emailed when deals critical to your business happen. Filter by region, industry and topics of interest.As seen onHave a login?Sign inRegister now!It's free!Use your social accountOr fill in the quick form:Register nowpromise we won't spamSign invia your social account:via your existing WGF account:Remember meRegister, it's freeForgot your password?SIGN INForgot your password?Enter your e-mail and we will send you your new password.reset passwordThe world's largest funding base/deals/295980-endurant-health-fund-lpsection=deals&subsection=detail&id=295980  




			Search deals by company name, industry, location, investors...			
			




SEARCH


Endurant Health Fund Lp raised $100,000,000 on November 6th, 2014.Get alertedif Endurant Health Fund Lp gets funded!Amount:$100,000,000Company:Endurant Health Fund LpInvestors:-Industry:FinanceCountry:State:City:United StatesCaliforniaSan MateoKey people:Pham Quang (Executive Officer) Vishal Saluja (Executive Officer)Data sources:www.sec.gov - D/A - Endurant Health Fund LP (0001588655) (Filer)Description:Endurant Health Fund Lp, a San Mateo, United States-based provider of Finance solutions, closed a investment of 100M in 2014, November 6th.Please note that all data is automatically extracted and errors can occur.The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.Inaccurate Data? Help us improve WhoGotFunded: post a comment!



ENDURANT CAPITAL MANAGEMENT LP- Ratings & Rankings by Symmetric




 






























Home
About

Pricing

Login


























ENDURANT CAPITAL MANAGEMENT LP



Register for more
















 ENDURANT CAPITAL Overview



												   Endurant Capital Management Lp is an investment advisor that manages 354 MM dollars in regulatory AUM and has 5 employees, of which 4 perform investment advisory functions. The manager's has disclosed holdings from 12/31/14 to 03/31/17. The fund's latest filing disclosed 309MM in positions, representing 87% of the manager's regulatory AUM.
												



Unlock Position Crowdedness, Turnover & Concentration









					
					 ENDURANT CAPITAL StockAlpha 
					
					






+3.4%





Top 25%



2.5yr StockAlpha
Register for more...
















Fundamental & Technical Factor Exposure
										






Market Cap
Beta
Volatility


Momentum (12M)
Momentum (6M)
Momentum (3M)


Price/Book
Price/Earnings
Price/Cash Flow


Dividend Yield
Sales Growth
Earnings Growth


ROE
ROA
ROC


EBIDTA Margin
Debt/Assets
Hedge Fund Crowding









 ENDURANT CAPITAL Since Last Filing Return Details
																										






Ticker
Size
Sector
Stock Move

StockAlpha Attribution
Days to Liquidate
Trade Crowdedness




ABT
4.45%
Health
14.15%

0.29%
0
26%



BDX
4.17%
Health
10.36%

0.17%
0
21%





Unlock Positions and Returns Details














×
Register to Unlock



Unlock profile and also get:

Manager Positions and Return Details
Position Crowdedness, Turnover & Concentration
Manager Performance Estimates
Top Stock Pickers Report













We take your privacy seriously. Your information will never be shared with any third party











×
Download PDF Report


								Your requested report is being generated and will be emailed to you when ready. If you do not receive the report, please check your spam folder, email info@symmetric.io or call 866-243-4178
								














FEATURED IN





















 ENDURANT CAPITAL Founders and Key Employees






Name
Title
In Position Since







Vishal Saluja
Managing Member And Portfolio Manager, Limited Partner
June-2013


Quang M. Pham
Member And Co-Portfolio Manager
June-2013


Brian C. Ronan
Chief Operating Officer And Chief Compliance Officer
August-2013


Ajim A. Tamboli
Partner And Analyst
August-2013










 ENDURANT CAPITAL Brokers, Custodians, Auditors and Administrators






Type
Company







Administrator
 Pro


Auditor
 Pro


Auditor
 Pro


Custodian
 Pro


Custodian
 Pro


Custodian
 Pro


Prime Broker
 Pro


Prime Broker
 Pro












 ENDURANT CAPITAL Investment Strategy


				
					   Methods of Analysis, Investment Strategies and Risk of Loss Investment Strategy Endurant Capital’s core strategy is to generate steady, risk-adjusted returns by investing in companies in the health care industry.   Endurant Capital intends to target companies that fit one of the following criteria when investing in long positions: a)         Leading “quality” healthcare  companies that  generate strong free cash flow, reinvest capital to sustain and accelerate top-line and earnings growth, and have a pathway to improving operating margins, and therefore, return on invested capital. b)         Companies, typically small- to mid-cap growth product companies, that are on the cusp or early stages of a robust and sustainable product cycle such that the market does not fully appreciate the extent of the market opportunity or the strength of the underlying technology. c)          Companies that have typically been unfairly punished as a resul...Unlock Full Investment Process Description







 ENDURANT CAPITAL Portfolio Concentration




Unlock Portfolio Concentration











 ENDURANT CAPITAL Location



1825 S. GRANT STREET								SUITE 425
SAN MATEO, 
California
UNITED STATES, 
94402








  ENDURANT CAPITAL Contact Information



							Phone Number: 650-539-5900
							Fax Number: 650-539-5999
							Website: null









READ RECENT SYMMETRIC REPORTS





















Disclaimer



				
		The information contained herein: (1) is proprietary to Symmetric and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Symmetric nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance and skill metrics are no guarantee of future results. "Symmetric," "Symmetric.io" and the Symmetric logo are marks of Symmetric, Inc. Read our privacy policy here. Read our terms of use here





















 Path A		  












Endurant Health Fund LP


















graypools
Sign in
Learn more







Endurant Health Fund LP
Hedge Fund






Institutional Investors

Hedge Funds

Endurant Health Fund LP





















Endurant Health Fund LP
is  a Delaware Hedge Fund located in San Mateo,
California.  
 

It was founded on Tuesday, October 01, 2013.






1825 South Grant Street
San Mateo,
California, 
94402 
United States
Phone: (650) 539-5905




Inception Date2013-10-01
Minimum Investment1.00M
CIK0001588655
JurisdictionDelaware
Updated2017-06-20 13:22:24.753574
NameEndurant Health Fund LP
Latest Filing2016-11-04
As of Date2016-11-04
Inception2013-10-01
EIN800945899
Form D File Number021-204226
Private Fund ID805-8446720063
Legal Entity TypeLimited Partnership











Statements



Commitments and Contributions


Private Investors












11-16
11-15
11-14




Commitments/Contributions
27.42M
120.00M
100.00M











11-16
11-15
11-14




Investors
25.00
24.00
4.00

































About /
Entities /
Legal
© 2017 Graypools LLC











Endurant Capital Management LP


















graypools
Sign in
Learn more







Endurant Capital Management LP
Fund Manager






Institutional Investors

Fund Managers

Endurant Capital Management LP





















Endurant Capital Management LP
is  a Delaware Fund Manager located in San Mateo,
California.  
 

It was registered on Wednesday, September 04, 2013.






1825 S. Grant Street
San Mateo,
California, 
94402 
United States
Phone: (650) 539-5900



Member and Co-Portfolio Manager
Quang Pham
Chief Compliance Officer
Chris Ronan
Managing Member and Portfolio Manager, Limited Partner
Vishal Saluja
Chief Operating Officer
Chris Ronan
Chief Operating Officer and Chief Compliance Officer
Brian Ronan
Partner and Analyst
Ajim Tamboli




Inception Date2013-09-04
JurisdictionDelaware
Updated2017-06-20 19:47:19.241583
As of Date2017-04-24
Latest Filing2017-04-24
SEC Number801-78451
CRD Number168707
Inception2013-09-04
Legal NameEndurant Capital Management LP
NameEndurant Capital Management LP
CIK0001633055
Legal Entity TypeLimited Partnership
EIN800938449











Holdings



Long Positions




Statements



Regulatory AUM


Employees






Funds



Hedge Funds: 5









Long Positions: 2017-03-31

SecurityValue



Abbott Laboratories (ABT)
13.76M


Becton Dickinson & CO (BDX)
12.88M


Universal Health Services, Inc (UHS)
11.84M


Shire PLC
11.52M


Davita Inc. (DVA)
10.77M


Aetna Inc  (AET)
9.93M


UnitedHealth Group Inc (UNH)
9.88M


Anthem, Inc. (ANTM)
9.28M


Jazz Pharmaceuticals (JAZZ)
8.87M


Oxford Immunotec Global PLC (OXFD)
8.84M


Catalent, Inc. (CTLT)
8.25M


Express Scripts Holding Co. (ESRX)
7.78M


Cardinal Health Inc (CAH)
7.61M


Pfizer Inc (PFE)
7.54M


VWR Corp (VWR)
7.23M


Celgene Corp  (CELG)
7.16M


Allergan plc (AGN)
6.55M


Walgreens Boots Alliance, Inc. (WBA)
6.30M


AmerisourceBergen Corporation (ABC)
6.17M


Thermo Fisher Scientific Inc. (TMO)
5.94M


Boston Scientific Corp (BSX)
5.63M


GLAXOSMITHKLINE PLC
5.55M


Stryker Corp (SYK)
5.41M


Hill-Rom Holdings, Inc. (HRC)
5.20M


Hologic Inc (HOLX)
5.09M


HealthSouth Corporation (HLS)
4.71M


Wright Medical Group N.V. (WMGI)
4.63M


CVS HEALTH Corp (CVS)
4.56M


Bard C R Inc  (BCR)
4.25M


Envision Healthcare Corp (EVHC)
4.04M


Zoetis Inc. (ZTS)
4.04M


Akorn Inc (AKRX)
3.81M


Mylan N.V. (MYL)
3.55M


Mallinckrodt plc (MNK)
3.13M


Biogen Inc. (BIIB)
3.07M


Centene Corp (CNC)
3.05M


Laboratory CORP of America Holdings (LH)
2.91M


Endologix Inc  (ELGX)
2.42M


K2M Group Holdings, Inc. (KTWO)
2.42M


Halozyme Therapeutics, Inc. (HALO)
2.28M


VanEck Vectors Biotech ETF
2.20M


Charles River Laboratories International Inc (CRL)
2.14M


FLUIDIGM CORP
2.13M


Clovis Oncology Inc. (CLVS)
2.03M


Medtronic plc (MDT)
2.01M


Edwards Lifesciences Corp (EW)
2.00M


Illumina Inc (ILMN)
1.83M


McKesson Corp (MCK)
1.79M


inCyte Corp (INCY)
1.76M


NanoString Technologies Inc (NSTG)
1.75M


TEVA PHARMACEUTICAL INDS LTD
1.69M


Nevro Corp (NVRO)
1.69M


Amicus Therapeutics Inc (FOLD)
1.59M


Aerie Pharmaceuticals Inc (AERI)
1.51M


Gilead Sciences Inc (GILD)
1.49M


LILLY Eli & Co (LLY)
1.49M


Newlink Genetics Corporation (NLNK)
1.43M


Varex Imaging Corp (VREX)
1.43M


Xenon Pharmaceuticals Inc. (XENE)
1.36M


Diplomat Pharmacy, Inc. (DPLO)
1.36M


Johnson & Johnson (JNJ)
1.26M


Conmed CORP (CNMD)
1.20M


Zosano Pharma Corp (ZSAN)
1.14M


PUMA BIOTECHNOLOGY INC
1.10M


Dermira, Inc. (DERM)
1.06M


Dynavax Technologies Corporation (DVAX)
1.03M


Patterson Companies, INC. (PDCO)
1.01M


TIVITY HEALTH INC
928.00K


Keryx Biopharmaceuticals Inc (KERX)
875.00K


Prothena Corp plc (PRTA)
815.00K


American Renal Associates Holdings, Inc. (ARA)
776.00K


Alder Biopharmaceuticals, Inc. (ALDR)
763.00K


HUMANA Inc (HUM)
742.00K


Zimmer Biomet Holdings, Inc. (ZBH)
716.00K


PerkinElmer Inc (PKI)
673.00K


INC Research Holdings, Inc. (INCR)
514.00K


Regeneron Pharmaceuticals Inc (REGN)
504.00K


Regenxbio Inc. (RGNX)
479.00K


BioMarin Pharmaceutical Inc (BMRN)
448.00K


Cigna Corp (CI)
439.00K


HCA Holdings, Inc. (HCA)
379.00K


Corvus Pharmaceuticals, Inc. (CRVS)
282.00K


Anaptysbio Inc (ANAB)
258.00K


SPDR SERIES TRUST
243.00K


Valeant Pharmaceuticals International, Inc. (VRX)
221.00K


Exelixis, Inc. (EXEL)
214.00K


Spark Therapeutics, Inc. (ONCE)
213.00K


OCERA THERAPEUTICS INC
200.00K











04-17
03-17
02-17




Regulatory Assets Under Management
542.63M
542.63M
542.63M











04-17
03-17
02-17




Employees
7.00
7.00
7.00







Hedge Funds: 2017-04-24



PM Manager Fund, SPC. - Segregated Portfolio 36
Cayman Islands


Endurant Health Fund LP
Delaware


Endurant Health Offshore Fund Ltd
Cayman Islands


Endurant Health Master Fund LP
Cayman Islands


PM Manager Fund, SPC. - Segregated Portfolio 33
Cayman Islands
































About /
Entities /
Legal
© 2017 Graypools LLC









Endurant Health Fund LP - Who is raising money? | SEC filings of fundraisings and investments in hedge funds, startups and private equity companies















Who is raising money?











Endurant Health Fund LP  Funding details


Endurant Health Fund LP Industry: Pooled Investment FundCIK Number: 0001588655IRS Number: 800945899Address: 1825 SOUTH GRANT STREET SUITE 425 SAN MATEO 94402Phone number: 650-539-5905



Latest news
Endurant Health Fund LP raised $27,420,911 from 25 investors on 2016-11-04.



Endurant Health Fund LP Filings

DateFiling TypeOfferedSoldRemainingMin. investmentInvest. countExemption / Exlusions
2016-11-04Amended Form DIndefinite$27,420,911Indefinite$1,000,0002506b 3C 3C.7[SEC Filing]2015-11-04Amended Form DIndefinite$120,000,000Indefinite$1,000,0002406b 3C 3C.7[SEC Filing]2014-11-06Amended Form DIndefinite$100,000,000Indefinite$1,000,000406b 3C 3C.7[SEC Filing]2013-10-08New Form DIndefinite$15,500,000Indefinite$1,000,000406b 3C 3C.7[SEC Filing]
Endurant Health Fund LP raised $27,420,911 in total.



Directors and Executives of Endurant Health Fund LP
Key People in Endurant Health Fund LP:

n/a Endurant Capital Management LPVishal SalujaPham Quang








Last visited companies: Streettalk Advisors Premier Fund, L.P., SweetWater Energy, Inc., TECHNOLOGY VENTURES FUND I, L.P., TEEC - The Engineering Essentials Company, LLC, TOSK INC

								© whoisraisingmoney.com
Daily updated news about investment into startups, hedge funds and private equity companies.
















Endurant Health Fund LP - List of CEOs, founders and company directors

















directorpedia.net - List of CEOs, founders, board members and company directors











Endurant Health Fund LP
List of persons related to the company Endurant Health Fund LP. Find out list of CEOs, founders, board members, and company directors of Endurant Health Fund LP.

CIK Number: 0001588655IRS Number: 800945899Company address: 1825 SOUTH GRANT STREET SUITE 425 SAN MATEO 94402Phone number: 650-539-5905



People related to Endurant Health Fund LP
NamePositionStreetCityCountryn/a  Endurant Capital Management LP1825 South Grant Street, Suite 425 San MateoCAQuang  PhamEndurant Capital Management LP 1825 South Grant Street, Suite 425San MateoCASaluja  VishalEndurant Capital Management LP 1825 South Grant Street, Suite 425San MateoCA




Endurant Health Fund LP on the Web












 











SEC Info - Endurant Health Fund LP - ‘D’ on 10/8/13










SEC Info uses JavaScript!  To view pages properly, enable JavaScript in your browser.


    SEC Info      Home      Search      My Interests      Help      Sign In      Please Sign In




Endurant Health Fund LP – ‘D’ on 10/8/13On:  Tuesday, 10/8/13, at 4:27pm ET   ·   Effective:  10/8/13   ·   Accession #:  1588655-13-1   ·   File #:  21-204226
Previous ‘D’:  None   ·   Next:  ‘D/A’ on 11/6/14   ·   Latest:  ‘D/A’ on 11/4/16



  in 
this entire Filing.
an "Entity" Search.
  Show 
Docs searched
 and 
every "hit".
the 1st "hit".

Help... Wildcards:  ? (any letter),  * (many).  Logic:  for Docs:  & (and),  | (or);  for Text:  | (anywhere),  "(&)" (near).    ↓Bottom
 
T-->  As Of                Filer                Filing    For·On·As Docs:Size

10/08/13  Endurant Health Fund LP           D          10/08/13    1:7KF-->Notice of an Offering of Securities Made Without Registration   —   Form DFiling Table of Contents
Document/Exhibit                   Description                      Pages   Size 

 1: D           Notice of an Offering of Securities Made Without    HTML      7K 
                          Registration -- primary_doc.xml/7.7                    

D-->P-->

This document is an XML File that may be rendered in various formats:Form D  –  Plain Text  –  EDGAR System  –  SEC Website  –  XML Listing  –  <?xml?> File  






The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.


﻿
UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM DNotice of Exempt Offering of Securities


OMB APPROVAL




OMB Number:
3235-0076


Estimated average burden


hours per response:
4.00









1. Issuer's Identity



CIK (Filer ID Number)
Previous Names



X
None



Entity Type


1588655

﻿



  
Corporation


X
Limited Partnership


  
Limited Liability Company


  
General Partnership


  
Business Trust


  
Other (Specify)




Name of Issuer


Endurant Health Fund LP


Jurisdiction of Incorporation/Organization


DELAWARE


Year of Incorporation/Organization






  
Over Five Years Ago


X
Within Last Five Years (Specify Year)
2013


  
Yet to Be Formed







2. Principal Place of Business and Contact Information



Name of Issuer


Endurant Health Fund LP


Street Address 1
Street Address 2


1825 SOUTH GRANT STREET
SUITE 425


City
State/Province/Country
ZIP/PostalCode
Phone Number of Issuer


SAN MATEO
CALIFORNIA
94402
650-539-5900



3. Related Persons



Last Name
First Name
Middle Name


Endurant Capital Management LP
n/a


Street Address 1
Street Address 2


1825 South Grant Street, Suite 425


City
State/Province/Country
ZIP/PostalCode


San Mateo
CALIFORNIA
94402






Relationship:
  
Executive Officer
  
Director
X
Promoter



Clarification of Response (if Necessary):General Partner



Last Name
First Name
Middle Name


Saluja
Vishal


Street Address 1
Street Address 2


Endurant Capital Management LP
1825 South Grant Street, Suite 425


City
State/Province/Country
ZIP/PostalCode


San Mateo
CALIFORNIA
94402






Relationship:
X
Executive Officer
  
Director
  
Promoter



Clarification of Response (if Necessary):



Last Name
First Name
Middle Name


Quang
Pham


Street Address 1
Street Address 2


Endurant Capital Management LP
1825 South Grant Street, Suite 425


City
State/Province/Country
ZIP/PostalCode


San Mateo
CALIFORNIA
94402






Relationship:
X
Executive Officer
  
Director
  
Promoter



Clarification of Response (if Necessary):
4. Industry Group







  
Agriculture



﻿
Banking & Financial Services



﻿



  
Commercial Banking


  
Insurance


  
Investing


  
Investment Banking


X
Pooled Investment Fund



﻿



X
Hedge Fund


  
Private Equity Fund


  
Venture Capital Fund


  
Other Investment Fund






﻿
Is the issuer registered as an investment company under the Investment Company Act of 1940? 



﻿



  
Yes
X
No





  
Other Banking & Financial Services





  
Business Services



﻿
Energy



﻿



  
Coal Mining






﻿



  
Electric Utilities






﻿



  
Energy Conservation






﻿



  
Environmental Services






﻿



  
Oil & Gas






﻿



  
Other Energy












﻿
Health Care



﻿



  
Biotechnology






﻿



  
Health Insurance






﻿



  
Hospitals & Physicians






﻿



  
Pharmaceuticals






﻿



  
Other Health Care





  
Manufacturing



﻿
Real Estate



﻿



  
Commercial






﻿



  
Construction






﻿



  
REITS & Finance






﻿



  
Residential






﻿



  
Other Real Estate














  



Retailing





  



Restaurants



﻿
Technology



﻿



  
Computers






﻿



  
Telecommunications






﻿



  
Other Technology






﻿
Travel



﻿



  
Airlines & Airports






﻿



  
Lodging & Conventions






﻿



  
Tourism & Travel Services






﻿



  
Other Travel








  



Other







5. Issuer Size










Revenue Range
OR
Aggregate Net Asset Value Range


  
No Revenues
  
No Aggregate Net Asset Value


  
$1 - $1,000,000
  
$1 - $5,000,000


  
$1,000,001 - $5,000,000
  
$5,000,001 - $25,000,000


  
$5,000,001 - $25,000,000
  
$25,000,001 - $50,000,000


  
$25,000,001 - $100,000,000
  
$50,000,001 - $100,000,000


  
Over $100,000,000
  
Over $100,000,000


  
Decline to Disclose
X
Decline to Disclose


  
Not Applicable
  
Not Applicable



6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)








﻿  
Rule 504(b)(1) (not (i), (ii) or (iii))



﻿  
Rule 504 (b)(1)(i)



﻿  
Rule 504 (b)(1)(ii)



﻿  
Rule 504 (b)(1)(iii)



﻿  
Rule 505



﻿X
Rule 506(b)



﻿  
Rule 506(c)



﻿  
Securities Act Section 4(a)(5)












X
Investment Company Act Section 3(c)









  
Section 3(c)(1)
  
Section 3(c)(9)  








  
Section 3(c)(2)
  
Section 3(c)(10)








  
Section 3(c)(3)
  
Section 3(c)(11)








  
Section 3(c)(4)
  
Section 3(c)(12)








  
Section 3(c)(5)
  
Section 3(c)(13)








  
Section 3(c)(6)
  
Section 3(c)(14)








X
Section 3(c)(7)










7. Type of Filing



X
New Notice

﻿
Date of First Sale
 10/1/13

﻿
  
First Sale Yet to Occur


  
Amendment



8. Duration of Offering



Does the Issuer intend this offering to last more than one year?

﻿



X
Yes
  
No






9. Type(s) of Securities Offered (select all that apply)









  
Equity
X
Pooled Investment Fund Interests


  
Debt
  
Tenant-in-Common Securities


  
Option, Warrant or Other Right to Acquire Another Security
  
Mineral Property Securities


  
Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security
  
Other (describe)



﻿

﻿



10. Business Combination Transaction



Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?

﻿



  
Yes
X
No






Clarification of Response (if Necessary):11. Minimum Investment



Minimum investment accepted from any outside investor
$1,000,000
USD



12. Sales Compensation




Recipient



Recipient CRD Number
X
None








(Associated) Broker or Dealer
X
None






(Associated) Broker or Dealer CRD Number
X
None





Street Address 1
Street Address 2


City
State/Province/Country
ZIP/Postal Code





State(s) of Solicitation (select all that apply)Check “All States” or check individual States
  
All States






  
Foreign/non-US







13. Offering and Sales Amounts



Total Offering Amount

﻿
USD



or
X
Indefinite





Total Amount Sold
$15,500,000
USD


Total Remaining to be Sold

﻿
USD



or
X
Indefinite






Clarification of Response (if Necessary):14. Investors






  



Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering.











﻿
Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:




4







15. Sales Commissions & Finder's Fees Expenses
Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.



Sales Commissions
$0
USD



  
Estimate





Finders' Fees
$0
USD



  
Estimate






Clarification of Response (if Necessary):16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.




﻿
$0
USD



  
Estimate






Clarification of Response (if Necessary):Signature and Submission
Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.
Terms of Submission



In submitting this notice, each issuer named above is:




Notifying the SEC and/or each State in which this notice is filed of the offering of
securities described and undertaking to furnish them, upon written request, in the accordance with applicable
law, the information furnished to offerees.*


Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator
or other legally designated officer of the State in which the issuer maintains its principal
place of business and any State in which this notice is filed, as its agents for service of
process, and agreeing that these persons may accept service on its behalf, of any notice,
process or pleading, and further agreeing that such service may be made by registered or
certified mail, in any Federal or state action, administrative proceeding, or arbitration
brought against it in any place subject to the jurisdiction of the United States, if the
action, proceeding or arbitration (a) arises out of any activity in connection with the
offering of securities that is the subject of this notice, and (b) is founded, directly or
indirectly, upon the provisions of:  (i) the Securities Act of 1933, the Securities Exchange
Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the
Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii)
the laws of the State in which the issuer maintains its principal place of business or any State
in which this notice is filed.


Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Regulation D for one of the reasons stated in Rule 505(b)(2)(iii) or Rule 506(d).





Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.
For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.



Issuer
Signature
Name of Signer
Title
Date




Endurant Health Fund LP
Vishal Saluja
Vishal Saluja
Founder
 10/8/13




* This undertaking does not affect any limits Section 102(a) of the National Securities Markets
Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996)] imposes on the ability of States to
require information. As a result, if the securities that are the subject of this Form D are "covered securities" for purposes
of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot
routinely require offering materials under this undertaking or otherwise and can require offering materials only to the
extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.
↑TopFiling Submission 0001588655-13-000001   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2017 Fran Finnegan & Company.  All Rights Reserved.About – Privacy – Redactions – Help —
Fri, 28 Jul 16:25:29.1 GMT 
 

Endurant Health Fund Lp - Funding history, company info, news ...































Want to see more?Want to find out who got funded, and who’s funding the next big thing? in real time? all across the world? tailored to your specific areas of focus?100+ deals per dayGet access to the most exhaustive worldwide funding watch on the web!Comprehensive funding informationKnow about who invested in a company, which sites covered the event, the funding history, etc.Exclusive insightsView original analytics such as most dynamic industries, most active investors, and more!Stay aware!Get emailed when deals critical to your business happen. Filter by region, industry and topics of interest.As seen onHave a login?Sign inRegister now!It's free!Use your social accountOr fill in the quick form:Register nowpromise we won't spamSign invia your social account:via your existing WGF account:Remember meRegister, it's freeForgot your password?SIGN INForgot your password?Enter your e-mail and we will send you your new password.reset passwordThe world's largest funding base/companies/129069-endurant-health-fund-lpsection=companies&subsection=detail&id=129069  




			Search deals by company name, industry, location, investors...			
			




SEARCH


Endurant Health Fund LpCompany DetailsGet alertedif Endurant Health Fund Lp gets funded!Endurant Health Fund LpFunding history Key peopleCountry:State:City:United StatesCaliforniaSan MateoIndustry:Finance Funding history DateDeal sizeInvestors November 6th, 2014$100,000,000-View DealOctober 8th, 2013$15,500,000-View DealCreate alertManage your alerts in accountWant to know when Endurant Health Fund Lp gets funded?Key peoplePham QuangExecutive OfficerVishal SalujaExecutive OfficerPlease note that all data is automatically extracted and errors can occur.The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.Inaccurate Data? Help us improve WhoGotFunded: post a comment!